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Abstract
Androstenedione (AD) is a steroid intermediate valuable for the production of steroid 
medicaments. Microbial biotransformation of phytosterol to produce AD is a well-
researched area. However, low substrate solubility of phytosterol in aqueous media and 
nucleus degradation of AD to androstadienedione (ADD) or 9-hydroxy-AD are the major 
obstacles for AD production leading to detailed research for optimization of biotransfor-
mation process. In this review, microbial transformation of AD with respect to the exist-
ing methods of chemical or biochemical synthesis of AD are extensively discussed. This 
review examines the microbial biotransformation process and limitations for enhanced 
AD production. Factors affecting the effective biotransformation process to obtain AD are 
discussed and limitations are highlighted. The main content of this review focuses on the 
recent and futuristic biotechnological advances and strategies in techniques to enhance 
AD bioprocess.
Keywords: androstenedione, microbial biotransformation, phytosterol, steroids, 
nucleus degradation
1. Introduction
Steroids are terpenoid lipids of specific structure that contain the nucleus of four cycloalkane 
rings. Androstenedione (AD) is a natural steroid which belongs to the 17-ketosteroid family. It 
is produced by the adrenal cortex and gonads. In the body, cholesterol leads to the formation 
of steroidal hormones. AD is a compound specifically used as a precursor for the majority of 
pharmaceutically active steroids such as testosterone, estradiol, ethinylestradiol, testolactone, 
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progesterone, cortisone, cortisol, prednisone and prednisolone [1]. The steroid pharmaceu-
ticals are of great importance for their role in the management of human fertility, osteopo-
rosis, menopause and blood pressure regulation [2, 3]. Commercially, steroid production 
represents one of the largest sectors of medical products manufactured by the pharmaceutical 
industry [4]. Production of AD and androstadienedione (ADD) exceeds 1000 tons per year in 
the world. Therefore, production of AD on a large scale with cost effective process becomes 
an area of demanding research in biotechnology. Apart from the broadly used natural com-
pounds, phytosterols gained an increasing importance as raw materials for the synthesis of 
steroidal drugs such as pregnenolone, boldenone, androstenedione and androstadienedione. 
The utilization of cholesterol and phytosterol as the sole carbon source by Mycobacterium sp. 
for growth and proliferation led to a serious development in microbial biotransformation 
processes for production of large number of steroidal compounds [1].
Phytosterols are thoroughly widespread in plants and are similar to cholesterol in terms of 
physiological functions and structure. Phytosterols differ from cholesterol by having a methyl 
or ethyl group at C-24 (Figure 1). Phytosterols participate in essential cellular processes since 
they modulate permeability and fluidity of membranes. In addition, they are precursors for 
the synthesis of steroid hormones and are involved in plant defense mechanisms. β-Sitosterol, 
campesterol, and stigmasterol are the main phytosterols found in plants (Figure 1). The most 
important phytosterols, β-sitosterol (C-29 carbon skeleton), campesterol (C-28), and stigmas-
terol (C-29), contribute up to 98% of all the phytosterols found in plants [5]. As cholesterol acts 
as a starting material for steroid production by adrenal cortex and gonads, phytosterol can act 
as a starting material for AD production by many microorganisms which are able to utilize 
phytosterols as carbon and energy source.
Figure 1. (A) Structure of cholesterol, (B) structure of campesterol, (C) structure of β-sitosterol, (D) structure of 
stigmasterol.
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This property is a key element in the steroid precursor production and, therefore can be 
exploited to make AD production a commercially viable process.
Further, phytosterols being a polar substance, has very low solubility in aqueous media. 
Because of low substrate solubility of phytosterols, the process of production of AD gets ham-
pered. Current review focuses on the mechanisms used for enhanced AD production, and 
includes current trends & future perspectives.
2. Synthesis of androstenedione from phytosterols
AD is synthesized in the body by adrenal cortex and gonads stimulating formation of testos-
terone or estradiol. Adrenocorticotropic hormone (ACTH) stimulates the steroid synthesis 
pathway from cholesterol leading to formation of AD. Phytosterol being similar to cholesterol 
is able to stimulate the formation of AD by its side-chain cleavage. (Elaboration of the path-
way in Figure 2).
As shown in the Figure 2, CYP11A1 is an enzyme that is responsible for side chain cleavage 
of the sterol resulting in AD formation.
2.1. Chemical synthesis
Marsh demonstrated a chemical synthesis of AD (aromatase inhibitors) which involves mul-
tiple steps [6]. AD can be produced chemically by addition of thiol reagents to appropri-
ate dienone intermediates. C19 steroids should retain the steroidal nucleus for their effective 
functions. However, the steroidal nucleus is sensitive to a temperature leading to its degrada-
tion [7]. Steroidogenic enzymes were also sensitive to endocrine-disrupting chemicals (EDCs) 
[8]. Apart from the above mentioned limitations, chemical synthesis leads to added costs and 
lower yield of AD with lengthy and sensitive procedures. Additionally, chemical synthesis of 
AD also requires use of toxic/harmful chemicals which affects the environment. Hence, there 
is a need to develop a process which is environment friendly and cost effective. Microbial 
biotransformation of phytosterol fulfills the need.
Figure 2. Side chain cleavage of sterol leading to AD formation.
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Figure 3. Enzymes involved in nucleus degradation of AD.
2.2. Biotransformation and substrates used
Sterol rich substrates are used to obtain steroidal intermediates by biotransformation. There 
are a number of organisms known to transform phytosterols to AD such as Aspergillus, 
Arthrobacter, Bacillus, Brevibacterium, Chryseobacterium, Fusarium, Gordonia, Nocardia, Pseudomonas, 
Rhodococcus, Streptomyces and Mycobacterium sp. [2, 3].
3. Factors affecting androstenedione production
3.1. Substrate solubility
Several researchers have reported their work in developing a microbial biotransformation 
process with high yield of AD with wide industrial applications [9–11]. Therefore, it was 
important to understand the factors affecting the actual biotransformation process. The basic 
and the most reported research is on low solubility of phytosterols in the aqueous media. This 
leads to low mass transfer rate and low substrate availability for conversion of phytosterol to 
AD. Oxygen transfer rate was also reported to be another critical parameter in the biotrans-
formation of phytosterol [12]. Along with oxygen transfer rate (OTR) the effect of by-products 
such as 1,4-HBC formed during the bioprocess was found to affect the amount of the products 
produced leading to a loss in yield by around 16.3 percent [12].
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3.2. Nucleus degradation
The change in the steroidal nucleus of AD is one of the major obstacles reported in the 
microbial biotransformation of phytosterols. After formation of AD during microbial bio-
transformation, further degradation of AD takes place producing either ADD or 9-hydroxy 
androstenedione (9-OHAD) [7]. In a phenomenon which was coined as nucleus degradation 
by the researchers, two major enzymes have been implicated so far: 3-ketosteroid-1,2-dehy-
drogenase (KsdD) was found to be responsible for AD to ADD conversion and hence lead to 
low yield of AD. 3-ketosteroid-9-hydroxylase (Ksh), was observed to be responsible for AD to 
9-OHAD conversion, leading to nucleus degradation and low yield of AD (Figure 3).
Xu et al. demonstrated that the enzymes involved in nucleus degradation of AD are tempera-
ture sensitive [7]. 3-ketosteroid-1,2-dehydrogenase (KsdD) and 3-ketosteroid-9-hydroxylase 
(Ksh) are enzymes sensitive at 37°. These enzymes break the B ring of steroidal nucleus which 
leads to degradation of the steroid. Hence it can be concluded that the microbial biotransfor-
mation of phytosterol is a temperature sensitive process.
4. Techniques to enhance production of androstenedione
As described earlier, to develop a process which is industrially applicable for high yields of 
AD, different techniques need to be incorporated. In the following section, we discuss the 
effective techniques to enhance AD production; thus making the process more economical.
4.1. Screening of micro-organisms
In the process of microbial biotransformation, selection of the microorganisms is a very cru-
cial step. Microorganisms which are able to utilize sterols as their sole energy and carbon 
source are reported to have the ability to produce AD as an intermediate in the sterol degra-
dation pathway [13]. Such microorganisms e.g., Mycobacterium sp., Mycobacterium smegmatis, 
Rhodococcus sp., Deinococcus radiodurans, Pseudomonas sp. have been documented to have an 
ability to produce AD or ADD. Table 1 illustrates the organisms which are able to utilize 
sterols as their sole carbon and energy source to produce steroidal intermediates, AD, ADD, 
9-hydroxy AD or 9-hydroxy ADD and also the various strategies implemented for enhancing 
the growth of the microorganisms.
4.2. Genome modifications
As mentioned in the earlier sections, researchers have demonstrated the pathways followed by 
microorganisms for biotransformation of phytosterol, the enzymes responsible for AD produc-
tion and its nucleus degradation. Various studies have been performed on genome sequencing 
and proteomics to determine the sequence of the genes involved in the side chain cleavage of 
phytosterol. CYP11A1 in Mycobacterium neoaurum was reported to be involved in side chain 
cleavage of phytosterol leading to formation of AD [14]. Further, as described in Section 
3.2, 3-ketosteroid-1,2-dehydrogenase (KsdD) and 3-ketosteroid-9-hydroxylase (Ksh) are the 
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enzymes responsible for nucleus degradation of AD. To avoid the nucleus degradation genome 
modification or mutation studies can be performed. Wei et al. has demonstrated a study to 
increase the yield of AD or ADD by mutations in Ksh or KsdD genes [14]. Ksh enzyme has two 
subunits namely A and B known as monooxygenase and reductase respectively. As described 
by Wei et al., the whole genome sequencing of Mycobacterium neoaurum explains six distantly 
placed gene clusters encoding KsdD enzyme and two gene clusters encoding KshA and KshB 
each. It was found that NwIB-02 Mycobacterium neoaurum with mutation in KsdD gene accu-
mulated AD as the main product. Besides that, double mutated mycobacterium neoaurum i.e. 
mutations in both KsdD and Ksh genes accumulated AD as the main product of microbial 
biotransformation of phytosterol. Cloning of any one of the genes encoding these enzymes into 
a more economically cultivable strain may lead to enhanced production of desired products.
4.3. Liquid polymer-based systems
As described earlier, low substrate solubility is one of the major obstacles in aqueous bio-
conversion systems involving hydrophobic compounds. Researchers derived an alternative 
of using organic solvents in the aqueous media to increase the substrate solubility and mass 
transfer. On the other hand, organic solvents are not environment friendly. An alternative to 
organic solvents are the use of supercritical fluids, liquid polymers, ionic liquids and natural 
oils [19, 20]. Such strategies also negate the drawbacks caused by organic solvents i.e. damag-
ing effects on microbial cells and its hazardous nature. Carvalho et al. demonstrated the use of 
poly (methylphenylsiloxane) oil (Silicone B oil) for AD extraction. It provides a suitable media 
for sitosterol side chain cleavage. AD yields close to 10 mM were obtained in almost 4–5 days 
of incubation, for an initial substrate concentration of 12 mM (referred to the polymer/organic 
solvent phase), with a biocatalyst concentration of 5 mg dry cell weight/ml. The researchers 
concluded the use of silicone B oil as non-volatile and non-toxic for providing a sustainable 
environment for the microbial side chain cleavage of sitosterol, both in single liquid phase 
system and in oil: aqueous two liquid phase systems.
Organism Product Strategy Reference
Mycobacterium neoaurum AD, ADD Three-stage fermentation [13]
Pseudomonas aeruginosa AD,ADD, B Selective media containing 
8- hydroxyquinoline
[10]
Nocardioides simplex AD, ADD, T Selective media containing Hp-β- CD [15]
Mycobacterium smegmatis AD, ADD Selective media containing Hp-β- CD [16]
Mycobacterium tuberculosis AD, ADD Selective media containing Hp-β- CD [17]
Moraxella ovis AD, ADD Natural medium containing rice bran oil [11]
Deinococcus radiodurans, AD, ADD Natural medium containing rice bran oil [11]
Corynebacterium equi AD, ADD Natural medium containing rice bran oil [11]
Corynebacterium urealyticum AD, ADD Natural medium containing rice bran oil [11]
Mycobacterium smegmatis AD, ADD Selective media [18]
AD: Androstenedione, ADD: androstadienedione, T: Testosterone, B: Boldenone.
Table 1. Microorganisms reported to have the ability to transform sterols to steroidal intermediates.
Secondary Metabolites - Sources and Applications120
To enhance the production of AD from phytosterol ionic liquid-aqueous biphasic systems 
were established by Yuan et al. [19]. Ionic liquids (ILs) with different cations and anions pro-
vided distinct but favorable substrate solubilization and product distribution for two phase 
conversion. The results of this study showed that AD production reached 2.23 g L−1 after 
5 days of biotransformation with substrate concentration of 5 g L−1. Further, ionic liquids 
which are easy to recycle produce negligible vapor pressure which indicates the industrial 
application of ILs in biphasic transformation process. Hence this strategy can be built up fur-
ther for a more scaled up production.
4.4. Three-stage fermentation system
A recent strategy employed for enhanced AD production is the use of three-stage fermen-
tation system. The well-known two-stage fermentation system uses a complex sugar (fruc-
tose in this case) as an initial carbon source followed by additional supplementation of simple 
sugar (glucose) which leads to elimination of the lag phase of the microorganism as well as an 
increase in biomass [21]. Shao et al. showed the effect of different carbon and energy sources on 
Mycobacterium neoaurum for enhancement of the desired steroid intermediate (AD/ADD) [13]. 
The researchers found that fructose acted as an optimal initial carbon source. Subsequent feed-
ing by glucose maintained the metabolism of mycobacterium neoaurum. The researchers pro-
posed three-stage fermentation by addition of phytosterol as third source and found enhanced 
ADD production (18.6 g/ l) which is reported to be the highest using mycobacterium neoaurum.
4.5. Use of PHB granules
Gerber et al. developed a whole–cell system based on recombinant Bacillus megaterium which 
encodes CYP11A1, the enzyme responsible for side chain cleavage of sterols [4]. The microor-
ganism’s PHB granules, aggregates of bioplastic coated with a protein/phospholipid mono-
layer act as substrate storage entities. As described earlier, substrate solubility of sterols in 
microbial biotransformation process is one of the major obstacles; PHB granules increase the 
conversion rate by serving as substrate storage entity. This phenomenon leads to increase 
in the mass transfer thereby increasing the desired product. Microorganisms which code 
for PHB production or the organisms having the ability to produce PHB granules can be 
screened for the biotransformation of sterols. These organisms may help in substrate avail-
ability thereby enhancing the efficiency of biotransformation process.
5. Conclusions
As per the available literature, there are number of strategies to increase the product yield. 
However, this area of research is still a hot topic as new strategies need to be developed which 
can lead to high yields of AD from cheaper substrates. Techniques involving industrially 
appropriate strains or addition of bioavailable catalysts to enhance the conversion or analysis 
of molecular pathway for generation of by-products. This may lead to development of a com-
mercially cost effective process with high yields of the desired product. AD being one of the 
most important steroids which has high demand in pharmaceuticals as it is the precursor for 
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widely marketed drug category known as steroids. Therefore, the industrial production of 
this compound will greatly benefit the biomedical sector.
6. Future perspectives
The industrial production of androstenedione is challenging and economically important.
Therefore upcoming research in this field will be focused on:
a. Bioprospecting for finding organisms with enhanced production of androstenedione
b. Process optimization for economically viable production
c. Developing industrially applicable techniques to enhance the yield of AD.
Although there are a number of strains reported to have the biotransformation ability, yet the 
efficacy of these strains does not match the industrial applicability. Hence the need of the hour 
is to look for organisms having the capacity of transforming phytosterols to AD with high effi-
ciency. Strategies can be applied for screening microorganisms having the ability to produce 
natural compounds like biosurfactants which increase the availability of complex substrates. 
Such organisms might play a role in substrate solubility of phytosterol thus minimizing the 
need of additional compounds.
Process optimization involves various parameters such as substrate inhibition, product inhibi-
tion, activities of biocatalysts, etc. To date, to the best of our knowledge, these parameters have 
not been addressed in the available literature. These parameters may result in the low yield 
of AD. Once addressed, these parameters might open a vast area of research. The mechanism 
of phytosterol biotransformation by various organisms has been reported but the enlisted 
parameters have not been paid attention to. All the aspects of the process need to be consid-
ered so as to develop an industrially applicable process for biotransformation of phytosterols.
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